Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 2,517 | 1,057 | 2,048 | 2,845 | 1,813 |
| Gross Profit | 2,517 | 1,057 | 2,048 | 2,845 | 1,813 |
| Operating Expenses | 18,330 | 21,805 | 22,329 | 21,111 | 19,835 |
| Operating Income | -15,813 | -20,748 | -20,281 | -18,266 | -18,022 |
| Other Income | 4,245 | 3,240 | 2,822 | 2,201 | 1,326 |
| Pre-tax Income | -11,568 | -17,508 | -17,459 | -16,065 | -16,696 |
| Net Income Continuous | -11,568 | -17,508 | -17,459 | -16,065 | -16,696 |
| Net Income | $-11,568 | $-17,508 | $-17,459 | $-16,065 | $-16,696 |
| EPS Basic Total Ops | -0.25 | -0.42 | -0.42 | -0.39 | -0.40 |
| EPS Basic Continuous Ops | -0.25 | -0.42 | -0.42 | -0.39 | -0.40 |
| EPS Diluted Total Ops | -0.25 | -0.42 | -0.42 | -0.39 | -0.40 |
| EPS Diluted Continuous Ops | -0.25 | -0.42 | -0.42 | -0.39 | -0.40 |
| EBITDA(a) | $-17,421 | $-22,118 | $-21,506 | $-19,155 | $-18,541 |